prednisone has been researched along with iguratimod in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Deng, W; Miao, C; Zhang, X | 1 |
Guo, C; Wu, R; Zheng, N | 1 |
Bian, W; Chen, D; Chen, J; Fu, J; Li, Y; Li, Z; Liu, Y; Sun, X; Zhang, W; Zhang, Y; Zhao, X | 1 |
3 other study(ies) available for prednisone and iguratimod
Article | Year |
---|---|
Abrupt generalized pustules in patients with rheumatoid arthritis and interstitial lung disease.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Arthritis, Rheumatoid; Biopsy; Chromones; Cyclosporine; Diagnosis, Differential; Exanthema; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Paeonia; Plant Extracts; Prednisone; Psoriasis; Skin; Sulfonamides | 2018 |
Iguratimod is effective in refractory rheumatoid arthritis patients with inadequate response to methotrexate-cyclosporin A-hydroxychloroquine-prednisone.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Chromones; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Sulfonamides; Treatment Outcome | 2018 |
Efficacy and safety of iguratimod on patients with relapsed or refractory IgG4-related disease.
Topics: Adult; Aged; Chromones; Cyclophosphamide; Female; Glucocorticoids; Humans; Immunoglobulin G; Immunoglobulin G4-Related Disease; Immunosuppressive Agents; Lacrimal Apparatus; Leflunomide; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisone; Recurrence; Retrospective Studies; Salivary Glands; Sulfonamides; Treatment Outcome; Young Adult | 2020 |